Research programme: varicella zoster vaccine - NovavaxAlternative Names: Shingles vaccine - Novavax; Varicella zoster virus (VZV) vaccine - Novavax; VZV VLP vaccine - Novavax
Latest Information Update: 09 Oct 2013
At a glance
- Originator Novavax
- Class Synthetic vaccines; Varicella vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- No development reported Varicella zoster virus infections
Most Recent Events
- 09 Oct 2013 No development reported - Preclinical for Varicella zoster virus infections (prevention) in USA (Parenteral)
- 19 Sep 2007 Early research in Varicella zoster virus infections in USA (Parenteral)